Join
Live feed
·
PRReleasevia Quantisnow
TScan Therapeutics Inc. logo

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies

ByQuantisnow·Wall Street's wire, on your screen.
TCRX· TScan Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRX (TScan Therapeutics Inc.) and more on Quantisnow.